{"id":"NCT01753570","sponsor":"Mitsubishi Tanabe Pharma Corporation","briefTitle":"Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)","officialTitle":"A Phase 3 Study of MP-424 in Combination With IFN Beta and RBV, in Subjects With Genotype 1/2 Hepatitis C, Who Are Treatment-Naïve or Have Received Interferon Based Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12","primaryCompletion":"2015-10","completion":"2015-10","firstPosted":"2012-12-20","resultsPosted":"2018-10-26","lastUpdate":"2018-10-26"},"enrollment":74,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C(CHC)"],"interventions":[{"type":"DRUG","name":"MP-424","otherNames":[]},{"type":"DRUG","name":"RBV(24 weeks)","otherNames":[]},{"type":"DRUG","name":"IFN beta(24 weeks)","otherNames":[]},{"type":"DRUG","name":"RBV(48 weeks)","otherNames":[]},{"type":"DRUG","name":"IFN beta(48 weeks)","otherNames":[]}],"arms":[{"label":"MP-424+RBV+IFN beta, Genotype1","type":"EXPERIMENTAL"},{"label":"RBV+IFN beta, Genotype1","type":"EXPERIMENTAL"},{"label":"MP-424+RBV+IFN beta, Genotype2","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the efficacy and safety of MP-424 with IFN beta and RBV in patients with genotype 1/2 hepatitis C, who are treatment-naïve or have received its treatment before.","primaryOutcome":{"measure":"Undetectable HCV (Hepatitis C Virus) RNA (Ribonucleic Acid) at 24 Weeks After Completion of Drug Administration (SVR, Sustained Viral Response)","timeFrame":"72 weeks(RBV+IFN beta), 48 weeks(MP-424+RBV+IFN beta)","effectByArm":[{"arm":"MP-424+RBV+IFN Beta, Genotype1","deltaMin":63.3,"sd":null},{"arm":"RBV+IFN Beta, Genotype1","deltaMin":20,"sd":null},{"arm":"MP-424+RBV+IFN Beta, Genotype2","deltaMin":71.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["28497489"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":30},"commonTop":["Pyrexia","Anaemia","Malaise","Headache","Blood uric acid increased"]}}